CP
Cytogel Pharma, LLC
SEC filingPharmaceuticals · Darien, CT
Amount raised$250Ksold at filing
Total offering$1M$750K still open
Investors in the raise3count reported to the SEC
FiledDec 23, 2025first sale Oct 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael W. UllmannDirector
Frederick W. TellingExecutive Officer, Director
Theodore W. MaioneExecutive Officer
Eric W. LangDirector
Steven W. ChrustDirector
C. Dean MaglarisExecutive Officer, Director
Jerry P. LeamonDirector
Cassandra P. KlimpDirector
Executive officers, directors and promoters as listed on the Form D.